The present invention provides ophthalmic therapeutic agent and the screening technique etc. of ophthalmic therapeutic agent.It addition, the present invention provides the Forecasting Methodology of the immunological rejection adjoint for the transplantation of retinal pigment epithelium cells of ophthalmic patient.